PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-03-30

Date Title Company
30-Mar-2021 Ottobock North America Appoints MedTech Industry Leader Marc C. Lundeberg as CEO & Regional President Newswire
30-Mar-2021 ​​​​​​​PAION AG REPORTS ON SUCCESSFUL FISCAL YEAR 2020 PAION AG
30-Mar-2021 Ori Biotech receives Frost & Sullivan’s 2021 Global Enabling Technology Leadership Award for cell and gene therapy manufacturing Ori Biotech
30-Mar-2021 PTC Therapeutics Announces the European Approval of Evrysdi™ for the Treatment of Spinal Muscular Atrophy PTC Therapeutics
30-Mar-2021 Genmab Announces European Marketing Authorization for Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis Genmab
30-Mar-2021 VFMCRP and Cara Therapeutics announce European Medicines Agency has accepted to review the Marketing Authorization Application for difelikefalin Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
30-Mar-2021 Amryt Announces Results from an Investigator Sponsored Study of Lomitapide in FCS Amryt
30-Mar-2021 Tiziana Plans Phase 2 Clinical Study in Moderate to Severe Covid-19 Patients with Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody Tiziana Life Sciences plc
30-Mar-2021 China Medical System (00867) Ushers in a Revaluation with its Continuous Growth and Synergy between Innovative Business and New Businesses ACN Newswire
30-Mar-2021 Reltio Launches Enterprise 360 Site Intelligence to Accelerate Clinical Trials Reltio
30-Mar-2021 NDA Group Releases Data Comparing FDA and EMA drug approvals in 2020 NDA Group
30-Mar-2021 Sputnik V vaccine authorized in Mali Russian Direct Investment Fund
30-Mar-2021 Ori Biotech receives Frost & Sullivan’s 2021 Global Enabling Technology Leadership Award for cell and gene therapy manufacturing Ori Biotech
30-Mar-2021 NERVE MATTERS: SCIENTIFIC STUDY IDENTIFIES ION CHANNEL COMPONENTS AS CRITICAL REGULATORS OF NEURONAL CONNECTIONS the Karl Landsteiner University of Health Sciences
30-Mar-2021 Tiziana Announces the FDA Has Allowed Treatment for a Secondary Progressive Multiple Sclerosis (SPMS) Patient for the Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, Under an Individual Patient Expanded Access Program Tiziana Life Sciences plc
30-Mar-2021 Arix leads $152 million Series B financing for Pyxis Oncology Arix Bioscience plc
30-Mar-2021 Higher Orange Consumption Linked To Increased Risk of Melanoma, New Study Suggests UK Biobank
30-Mar-2021 BioNTech Announces Full Year 2020 Financial Results and Corporate Update BioNTech
30-Mar-2021 PENTAX Medical’s online hygiene event provides platform for expert insights: Ways to further improve patient safety in endoscopy PENTAX Medical
30-Mar-2021 Santhera Completes Capital Increase for Financing Arrangements Santhera